BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare - Seite 2

• MRNA Scientific Directors:
  • Mr. Kenny Lai
  • Mr. CC Wong
• AISB Directors:
  • Mr. Andrew Teng (Chief Executive Officer, CEO)
  • Mrs. Penny Attenbrough (Chief Strategy Officer, CSO)

Expanding Market Reach:

• MRNA Scientific and BGLC believe that this strategic investment will allow BGLC’s Blood-based Genomic Screening (BGS) liquid biopsies and other diagnostic services to be better marketed and accessible to a wider range of customers and healthcare providers, through integration into AISB’s aiCMS and the aiCARE app, enabling direct booking via healthcare providers and patients.
• By combining MRNA’s expertise in genomics and AISB’s innovative platform, patients and healthcare professionals will benefit from advanced diagnostics and personalized care.

Digital Health & AI Market:

• The global digital health market size was estimated at USD 240.9 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 21.9% from 2024 to 2030¹.
• The global market size for AI in Healthcare is expected to reach USD 187.7 billion by 2030 with a compound annual growth rate (CAGR) of 38.5% from 2024 to 2030².
• Given the market size and opportunities in Digital Health and AI in Healthcare, MRNA and BGLC will closely consider opportunities to increase our participation in this market, including the potential to increase our investment in AISB and other technology platforms.
  

AISB’s Projections:

• Projected Revenue in Malaysia:
  • As stated in its investment documents, AISB anticipates substantial revenue growth driven by increased adoption of aiCMS, with projections reaching RM 75million collectively for 2024-2028.
  • The platform’s comprehensive suite of services positions it as a game-changer in the Malaysian healthcare landscape.
  • These revenue projections were part of the approved prospectus on the Securities Commission of Malaysia approved pitchIN Funding platform.
    
• Clinics and Service Providers:
  • AISB aims to onboard a significant number of healthcare and wellness providers, and corporations.
  • Since its recent launch, aiCMS has already proven market traction with over 30 healthcare providers and corporations in its initial segue into this broad market.